Invasive Pneumococcal Disease in Adults in Portugal: The Importance of Serotypes 8 and 3 (2015–2018)

Invasive Pneumococcal Disease in Adults in Portugal: The Importance of Serotypes 8 and 3 (2015–2018)

Increasing the uptake of the 13-valent pneumococcal conjugate vaccine (PCV13) in children is expected to alter the serotypes causing invasive pneumococcal disease (IPD) in adults due to herd protection. We characterized 2172 cases of adult IPD in 2015–2018 in Portugal after the introduction of PCV13...

Full description

Bibliographic Details
Main Authors:	Catarina Silva-Costa, Joana Gomes-Silva, Inês Teodoro, Mário Ramirez, José Melo-Cristino, on behalf of the Portuguese Group for the Study of Streptococcal Infections
Format:	Article
Language:	English
Published:	MDPI AG 2021-05-01
Series:	Microorganisms
Subjects:	conjugate vaccine polysaccharide vaccine serotype invasive disease epidemiology antimicrobial resistance
Online Access:	https://www.mdpi.com/2076-2607/9/5/1016

Similar Items

Serotype 3 remains the leading cause of invasive pneumococcal disease in adults in Portugal (2012-2014) despite continued reductions in other 13-valent conjugate vaccine serotypes.
by: Andreia N Horácio, et al.
Published: (2016-10-01)

Pediatric Invasive Pneumococcal Disease Three Years after PCV13 Introduction in the National Immunization Plan—The Continued Importance of Serotype 3
by: Catarina Silva-Costa, et al.
Published: (2021-07-01)

Pediatric Complicated Pneumonia Caused by Streptococcus pneumoniae Serotype 3 in 13-Valent Pneumococcal Conjugate Vaccinees, Portugal, 2010–2015
by: Catarina Silva-Costa, et al.
Published: (2018-07-01)

Immunological and Epidemiological Aspects of the Immunogenicity of Streptococcus Pneumoniae Serotype 3 Capsular Polysaccharide in Pneumococcal Vaccines
by: A. E. Zaitsev, et al.
Published: (2020-04-01)

Pneumococcal Serotypes before and after Introduction of Conjugate Vaccines, United States, 1999–2011
by: Sandra S. Richter, et al.
Published: (2013-07-01)

Should Pneumococcal Serotype 3 Be Included in Serotype-Specific Immunoassays?
by: Ezra Linley, et al.
Published: (2019-01-01)

Recommendation for use of the newly introduced pneumococcal protein conjugate vaccines in Korea
by: Eun Hwa Choi, et al.
Published: (2011-04-01)

Pediatric Pneumococcal Serotypes in 4 European Countries
by: Germaine Hanquet, et al.
Published: (2010-09-01)

Prevalence of pneumococcal nasopharyngeal colonization and serotypes circulating in Cameroonian children after the 13-valent pneumococcal conjugate vaccine introduction
by: John Njuma Libwea, et al.
Published: (2020-09-01)

From Immunologically Archaic to Neoteric Glycovaccines
by: Marco Cavallari, et al.
Published: (2017-01-01)

NEXT GENERATION PNEUMOCOCCAL CONJUGATE VACCINES EFFICACY AND EFFECTIVENESS IN DIFFERENT REGIONS OF THE WORLD
by: O. P. Kovtun, et al.
Published: (2014-01-01)

SEROTYPE-INDEPENDENT VACCINES AGAINST PNEUMOCOCCAL INFECTION
by: I. B. Semenova, et al.
Published: (2016-08-01)

Distribution of Streptococcus pneumoniae serotypes in the northeast macro-region of São Paulo state/Brazil after the introduction of conjugate vaccine
by: Marta Inês Cazentini Medeiros, et al.
Published: (2017-08-01)

The Analysis of Scientific Data on the Efficacy of Pneumococcal Conjugated Vaccine in the Cohort of Children with Bronchial Asthma
by: Tatiana A. Kaliuzhnaia, et al.
Published: (2020-11-01)

Divergent serotype distribution between children with otitis media and those without in the pneumococcal conjugate vaccine era
by: Chih-Ho Chen, et al.
Published: (2020-12-01)

Streptococcus pneumoniae serotype distribution in Vojvodina before the introduction of pneumococcal conjugate vaccines into the national immunization program
by: Petrović Vladimir, et al.
Published: (2016-01-01)

The Impact of Pneumococcal Conjugate Vaccine (PCV) Coverage Heterogeneities on the Changing Epidemiology of Invasive Pneumococcal Disease in Switzerland, 2005–2019
by: Oluwaseun Rume-Abiola Oyewole, et al.
Published: (2021-05-01)

Safety and Immunogenicity of Heptavalent Pneumococcal Conjugate Vaccine Booster in Taiwanese Toddlers
by: Pei-Lan Shao, et al.
Published: (2006-01-01)

Pneumococcal Serotype–specific Unresponsiveness in Vaccinated Child with Cochlear Implant
by: Elaine Stanford, et al.
Published: (2012-06-01)

Poor Potential Coverage for 7-Valent Pneumococcal Conjugate Vaccine, Malawi
by: Stephen B. Gordon, et al.
Published: (2003-06-01)

Post–13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children
by: Corinne Levy, et al.
Published: (2021-08-01)

Epidemiology of Serotype 1 Invasive Pneumococcal Disease, South Africa, 2003–2013
by: Claire von Mollendorf, et al.
Published: (2016-02-01)

Vaccine Prevention of Pneumococcal Infection in Children
by: Alexander A. Baranov, et al.
Published: (2018-07-01)

The Role of Serotype-Specific Immunological Memory in Pneumococcal Vaccination: Current Knowledge and Future Prospects
by: Ioanna Papadatou, et al.
Published: (2019-01-01)

Rapid Spread of Pneumococcal Nonvaccine Serotype 7C Previously Associated with Vaccine Serotype 19F, England and Wales
by: Ashley Makwana, et al.
Published: (2018-10-01)

Invasive pneumococcal disease in persons with predisposing factors is dominated by non-vaccine serotypes in Southwest Sweden
by: Karin Bergman, et al.
Published: (2021-08-01)

Empyema due to Streptococcus Pneumoniae Serotype 9V in a Child Immunized with 13-Valent Conjugated Pneumococcal Vaccine
by: Murat Sütçü, et al.
Published: (2017-02-01)

A Population-Based Descriptive Atlas of Invasive Pneumococcal Strains Recovered Within the U.S. During 2015–2016
by: Bernard Beall, et al.
Published: (2018-11-01)

Non-invasive pneumococcal pneumonia in Portugal--serotype distribution and antimicrobial resistance.
by: Andreia N Horácio, et al.
Published: (2014-01-01)

Rationale and methods of a randomized controlled trial of immunogenicity, safety and impact on carriage of pneumococcal conjugate and polysaccharide vaccines in infants in Papua New Guinea
by: Deborah Lehmann, et al.
Published: (2017-12-01)

EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE: EMERGING DATA FROM INVASIVE PNEUMOCOCCAL DISEASE, PNEUMONIA, ACUTE OTITIS MEDIA AND NASOPHARYNGEAL CARRIAGE
by: Ralf Rene Reinert, et al.
Published: (2012-06-01)

ROLE OF STREPTOCOCCUS PNEUMONIAE IN THE STRUCTURE OF BACTERIAL INFECTIONS IN THE CHILDREN HOSPITALIZED TO INPATIENT HOSPITALS IN MOSCOW IN 2011–2012
by: A. A. Baranov, et al.
Published: (2013-09-01)

Development and evaluation of a novel vaccine against prevalent invasive multi-drug resistant strains of Streptococcus pneumoniae
by: Rehab H. Bahy, et al.
Published: (2016-11-01)

Effects of Pneumococcal Conjugate Vaccine on Genotypic Penicillin Resistance and Serotype Changes, Japan, 2010–2017
by: Kimiko Ubukata, et al.
Published: (2018-11-01)

Changes in the pneumococcal vaccine serotypes in adult noninvasive pneumonia after the introduction of pneumococcal conjugate vaccination for children
by: Hiroaki Takeda, et al.
Published: (2019-01-01)

Pneumococcal Disease Prevention: Are We on the Right Track?
by: Nicola Principi, et al.
Published: (2021-03-01)

Procedure for the conjugation of the Streptococcus pneumoniae serotype 6B capsular polysaccharide to the tetanus toxoid
by: Jean P Soubal, et al.

Pneumococcal Colonization in the Familial Context and Implications for Anti-Pneumococcal Immunization in Adults: Results from the BINOCOLO Project in Sicily
by: Fabio Tramuto, et al.
Published: (2017-01-01)

Invasive Pneumococcal Disease in Latvia in PCV10 Vaccination Era, 2012–2018
by: Larisa Savrasova, et al.
Published: (2021-10-01)

A case report of parapneumonic pleural effusion caused by Streptococcus pneumoniae serotype 19A in a child immunized with 13-valent conjugate pneumococcal vaccine
by: Idrissa Diawara, et al.
Published: (2017-04-01)